Recurrence and restart of sirolimus in vascular anomalies after withdrawal

J Dermatol. 2023 Apr;50(4):e119-e120. doi: 10.1111/1346-8138.16649. Epub 2022 Nov 28.

Authors

Hongyuan Liu¹, Xi Yang¹, Hechen Jia¹, Li Hu¹, Zian Xu¹, Hui Chen¹, Xiaoxi Lin¹

Affiliation

¹ Plastic and Reconstructive Department, Shanghai Ninth People's Hospital, Shanghai, China.

PMID: 36440961
DOI: 10.1111/1346-8138.16649

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Immunosuppressive Agents / adverse effects
Sirolimus / therapeutic use
Vascular Diseases*
Vascular Malformations* / drug therapy

Substances

Sirolimus
Immunosuppressive Agents

Grants and funding